Minskintercaps, Slovak Vita Pharma to implement $46mn project


Belarusian Minskintercaps and the Slovak company Vita Pharma have launched a $46 million project to produce pharmaceuticals, announced Business Development Director of Vita Pharma Nikolai Zemskov.

Due to the lack of available resources, Minskintercaps was looking for an investor. As a result the company entered into partnership with Slovak Vita Pharma to create VitaMic. To date VitaMic is preparing a detailed business plan of the project. Apart from the Slovak partners, the project will involve companies from India and Serbia.

There are plans to establish the production of newest medicines at reasonable prices for the Belarusian market. The new facility will produce 45 new medicines.

All this will make Belarus more independent from foreign medicines and raise its export capacity. The main areas of import substitution will become oncology, oncohematology, transplantology, HIV, AIDS, hematology, immunology, etc.

Prime Minister Sergei Sidorsky visited Minskintercaps on 10 December. He got acquainted with the production management and answered the questions of the personnel.

According to www.belta.by